FDA Investigator Davinna Ligons, PhD

Davinna Ligons, PhD has conducted inspections on 3 sites in 2 countries as of 23 Apr 2019. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:

Last Inspection Date:

23 Apr 2019

Investigator Role:

FDA Investigation Participant

Redica ID:

100005146

Countries of Inspections:

United States of America, Korea (Republic of)

FDA Investigators that have inspected at least one site in common with Davinna Ligons, PhD:

Alicia M Mozzachio, Amalia C Himaya, Amanda L Fyles, Anita Narula, PhD, Barry Cherney, PhD, Bichsa T Tran, Bo Chi, PhD, Brien C Fox, Bryan A Galvez, Carla J Lundi, Caryn M Mcnab, Cheron M Portee, Christina C Santos, Christina V Santos, Christopher R Czajka, Daniel W Cline, Diane Cvan Leeuwen, Diane L Raccasi, Doan T Nguyen, PharmD, Donna Ltartaglino Besone, Dr. Jun Liu, PhD, Dr. Zhihao Qiu (Peter), PhD, Ennan Guan, Esther C Broner, PhD, Frances Namuswe, PhD, Haley H Seymour, Haroon Vohra (NMI), Hasan A Irier, PhD, Ian L Mcwilliams, Iris C Macinnes, James R Fleckenstein, Jee Chung, PhD, Jeffrey P Raimondi, Jennifer Gogley, Jennifer M Gogley, Joel Welch, PhD, John R Myung, Junho Pak, Ka L Wong, Kathleen R Jones, PhD, Kelvin Cheung, Kelvin X Sanders, Kendra A Biddick, Kim Lthomas Cruse, Kristen Nickens, PhD, Laura Fontan, MS, Leonard H Lavi, Lindsey Brown, PhD, Marcia B Williams, Marcus F Yambot, Maxyne T Lam, Michael Shanks, MS, Michelle A Marsh, Mihaly S Ligmond, Mohsen Rajabi Abhari, FDA, Nicholas Obiri, PhD, Nicola M Fenty Stewart, Omotunde O Osunsanmi, Peter S Diak, Rebecca Rodriguez, Richmond K Yip, Robert D Tollefsen, Robert Darius, Roger F Zabinski, Rona Leblanc, PhD, Ronald L Koller, Ronda Leblanc, Sarah Arden, Scott R Nichols, PhD, Sidney B Priesmeyer, Sonia R Peterson, Sonya M Edmonds, Stanley Au, Steven Fong, MS, PhD, Taichun Qin, PhD, Tamika White, Terri L Dodds, Thao T Kwan, Thao X Tran, Thuy T Nguyen, LCDR, Uttaniti Limchumroon (Tom), Viviana Matta, Yi Wang, PhD, Yumi J Hiramine, Yun Wu, PhD, Yvonne C Wilkes

Davinna Ligons, PhD's Documents

Publish Date	Document Type	Title
November, 2017	EIR	Daewoong Pharmaceutical Co. Ltd. - EIR, 2017-11-17
March, 2018	FDA 483 Response	Amgen, Inc - Form 483R, 2018-04-05
March, 2018	FDA 483	Amgen, Inc - Form 483, 2018-03-16
May, 2019	FDA 483	Tanvex BioPharma USA, Inc - Form 483, 2019-05-02
November, 2017	FDA 483	Daewoong Pharmaceutical Co. Ltd. - Form 483, 2017-11-17

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more